BENZTROPINE MES 2 MG TABLET
For 30 tablets
Pharmacies pay
$2.72 filed
30 × $0.09059 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$6.99 filed
30 × $0.23308 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.6× estimated
Medicare paid 2.6× what pharmacies pay.
Part D averages every strength and form sold under “Benztropine Mesylate*” / “Benztropine Mesylate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$8.13 estimated
$2.72 + $0.41 (15%) + $5.00 fee per fill = $8.13
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BENZTROPINE MES 2 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “benztropine mesylate” and “benztropine”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Par Health USA, LLC, Major Pharmaceuticals and SUNRISE PHARMACEUTICAL, INC.
FDA lists it under 2 Established Pharmacologic Classes: Anticholinergic and Antihistamine.
The NADAC file of 2026-10-14 prices it under 18 NDCs (National Drug Codes); the FDA directory lists 17 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.72 for 30 tablets (30 × $0.09059 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 9 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Chartwell RX, LLC. | 4 | $0.09059 per EA filed |
| Leading Pharma, LLC | 2 | $0.09059 per EA filed |
| Par Health USA, LLC | 2 | $0.09059 per EA filed |
| QUAGEN PHARMACEUTICALS LLC | 2 | $0.09059 per EA filed |
| SUNRISE PHARMACEUTICAL, INC | 2 | $0.09059 per EA filed |
| ScieGen Pharmaceuticals Inc | 2 | $0.09059 per EA filed |
| American Health Packaging | 1 | $0.09059 per EA filed |
| Cipla USA Inc. | 1 | $0.09059 per EA filed |
| Major Pharmaceuticals | 1 | $0.09059 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.09059 per EA filed |
All 18 NDCs, with labeler and price
- 00603-2435-21 · Par Health USA, LLC · $0.09059 per EA · eff. 2026-09-23 filed
- 00603-2435-32 · Par Health USA, LLC · $0.09059 per EA · eff. 2026-09-23 filed
- 00904-7290-61 · Major Pharmaceuticals · $0.09059 per EA · eff. 2026-09-23 filed
- 11534-0169-09 · SUNRISE PHARMACEUTICAL, INC · $0.09059 per EA · eff. 2026-09-23 filed
- 11534-0169-10 · SUNRISE PHARMACEUTICAL, INC · $0.09059 per EA · eff. 2026-09-23 filed
- 50228-0227-01 · ScieGen Pharmaceuticals Inc · $0.09059 per EA · eff. 2026-09-23 filed
- 50228-0227-10 · ScieGen Pharmaceuticals Inc · $0.09059 per EA · eff. 2026-09-23 filed
- 62135-0142-01 · Chartwell RX, LLC. · $0.09059 per EA · eff. 2026-09-23 filed
- 62135-0142-10 · Chartwell RX, LLC. · $0.09059 per EA · eff. 2026-09-23 filed
- 62135-0142-18 · Chartwell RX, LLC. · $0.09059 per EA · eff. 2026-09-23 filed
- 62135-0142-57 · Chartwell RX, LLC. · $0.09059 per EA · eff. 2026-09-23 filed
- 68084-0389-01 · American Health Packaging · $0.09059 per EA · eff. 2026-09-23 filed
- 68084-0389-11 · not listed as a package in the FDA directory · $0.09059 per EA · eff. 2026-09-23 filed
- 69097-0832-07 · Cipla USA Inc. · $0.09059 per EA · eff. 2026-09-23 filed
- 69315-0138-01 · Leading Pharma, LLC · $0.09059 per EA · eff. 2026-09-23 filed
- 69315-0138-10 · Leading Pharma, LLC · $0.09059 per EA · eff. 2026-09-23 filed
- 70752-0125-10 · QUAGEN PHARMACEUTICALS LLC · $0.09059 per EA · eff. 2026-09-23 filed
- 70752-0125-11 · QUAGEN PHARMACEUTICALS LLC · $0.09059 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share an FDA nonproprietary name with BENZTROPINE MES 2 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| BENZTROPINE MES 0.5 MG TAB | $0.06474 per EA filed | $0.23308 per EA filed |
| BENZTROPINE MES 1 MG TABLET | $0.0753 per EA filed | $0.23308 per EA filed |
| BENZTROPINE MES 2 MG TABLET this page | $0.09059 per EA filed | $0.23308 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 18 NDCs’ NADAC prices is $0.09059 per EA filed.
Of the 23 other products in FDA’s Anticholinergic class priced per EA, 19 have a higher middle NADAC price and 4 a lower one. The one in the middle is SCOPOLAMINE 1 MG/3 DAY PATCH, at $4.33565 per EA filed (eff. 2026-09-23).
Of the 21 other products in FDA’s Antihistamine class priced per EA, 14 have a higher middle NADAC price and 7 a lower one. The one in the middle is GS SLEEP AID ULTRA 25 MG TAB, at $0.11579 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $6.99 for 30 tablets, at an average of $0.23308 per EA in 2024 (2024-01-01 to 2024-12-31) for “Benztropine Mesylate*” and “Benztropine Mesylate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,944,678 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for BENZTROPINE MES 2 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Benztropine Mesylate* / Benztropine Mesylate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 52 NADAC NDCs the name join matched to it have an FDA route including ORAL. 3 of the 52 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).
Related pages
Its pharmacologic classes
Related in the same class
- TRELEGY ELLIPTA 100-62.5-25
- HYDROXYZINE HCL 10 MG TABLET
- DICYCLOMINE 20 MG TABLET
- IPRATROPIUM BR 0.02% SOLN
- HYDROXYZINE PAM 100 MG CAP